About Us
Research
Research
Latest Research News!
Background to research
Current Research
Previous Research Stories
Donating tissue for research
Donating tissue after death
Support
Giving & Events
Contact Us
Donate
Text Size
Contact Us
About Us
Our Background
Charity Origins
The Good Business Charter
Our Team
Join Team YBTC
Meet Our Team
Meet Our Patrons & Celebrity Ambassadors
Meet Our Ambassadors
Meet Our Volunteers
Beefy's Charity Foundation
Current Funds
Safeguarding
Research
Research
Latest Research News!
Background to research
Current Research
Previous Research Stories
Donating tissue for research
Donating tissue after death
Support
Support Services
Welfare Advice & Guidance
1-2-1 Peer Support
Peer Support Groups
Peer Support Walks
YBTC Support Line
Other Resources
Signs & Symptoms of a brain tumour
Managing anxiety before a scan
Travelling abroad after a diagnosis
Driving & transport after your diagnosis
Radiotherapy Masks
The Brain Tumour Patients' Charter of Rights
Giving & Events
Loving Fundraising
YBTC Events
Community Fundraising
Corporate Partnerships
Trusts & Foundations
Loving Shopping
YBTC Online Shop
Loving Giving
Donate Online
Other Ways To Donate
Payroll Giving
Regular Giving
Remember a loved one
Legacy Gifting
Contact Us
Research
Research
Previous Research Stories
Improving steroid safety in glioblastoma
Improving steroid safety in glioblastoma
It has been observed that steroids may reduce the efficiency of standard treatments for glioblastoma.
This one year study looks at new selective steroids.
Official Title:
Improving steroid safety in glioblastoma
Lead Researcher:
Laura Matthews
Where:
Leeds, West Yorkshire
When:
1 year, 2020
Cost:
£55,000
Research Type:
Glioblastoma
Glioblastoma (GBM) tumours directly cause inflammation and swelling which is further compounded by each component of standard GBM therapy - surgery, radiotherapy and chemotherapy.
Anti inflammatory steroids are prescribed to reduce inflammation and form an essential part of most cancer therapies. Whilst reducing inflammation in almost every patient it has been observed that steroids may reduce the efficiency of standard treatments.
A new generation of anti-inflammatory drugs is required.
This ia a one year project funded solely by Yorkshire's Brain Tumour Charity.
Significant data has been obtained previously from a 3 year PhD studentship researching this subject.
It is planned to screen four new selective steroids to determine if they can – with equal effect to conventional steroids – reduce inflammation in GBM cells, without influencing the efficacy of radiotherapy or chemotherapy.
All experiments will use current widely prescribed steroids as controls.
Researcher: Kathryn McGinnis
CLICK HERE
for more information
Lead: Dr Laura Matthews
CLICK HERE
for more information
Since 2003 you've helped us raise:
4,807,665.73
Helpful Links
Registered Charity No. 1095931
Contact Us
Office
Phone: 0113 340 0111
Email:
info@yorksbtc.org.uk
Support
Phone: 0113 511 8111
Email:
ybtcsupport@yorksbtc.org.uk
Find Us
Yorkshire's Brain Tumour Charity
31 Otley Road,
Headingley,
Leeds,
LS6 3AA
Yorkshire's Brain Tumour Charity, Registered Charity Address 31 Otley Road, Headingley, Leeds, LS6 3AA.
© Yorkshire's Brain Tumour Charity. Registered Charity No. 1095931
Privacy Policy
|
Cookie Policy
|
Refund Policy
|
Fundraising Promise
|
Complaints Policy
|
Covid-19
by pixelbuilders.com |
digital agency leeds
Make a Donation